NASDAQ : WOK
WORK Medical Technology Group LTD — Key statistics
Healthcare · Medical Devices · China
Last price 1.1 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 2.66M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 2.47M |
| Enterprise Value | 5.84M |
Dates
| Measure | Value |
|---|
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 2.42M |
| Shares Outstanding | 2.42M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.04% |
| Owned by Institutions (%) | 5.57% |
| Float | 2.30M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.23 |
| Forward PS | n/a |
| PB Ratio | 0.07 |
| P/TBV Ratio | 0.08 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 0.54 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.37 |
| Quick Ratio | 0.33 |
| Debt / Equity | 0.20 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -13.35 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -19.23% |
| Return on Assets (ROA) | -6.73% |
| Return on Invested Capital (ROIC) | -12.46% |
| Return on Capital Employed (ROCE) | -13.75% |
| Weighted Average Cost of Capital (WACC) | 6.63% |
| Revenue Per Employee | $45,033 |
| Profits Per Employee | -$18,892 |
| Employee Count | 238 |
| Asset Turnover | 0.26 |
| Inventory Turnover | 3.63 |
Taxes
| Measure | Value |
|---|
| Income Tax | 210,651 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.74 |
| 52-Week Price Change | -100.00% |
| 50-Day Moving Average | 1.69 |
| 200-Day Moving Average | 62.14 |
| Relative Strength Index (RSI) | 30.85 |
| Average Volume (20 Days) | 39,578 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 139,363 |
| Short Previous Month | 136,826 |
| Short % of Shares Out | 5.76% |
| Short % of Float | 6.07% |
| Short Ratio (days to cover) | 2.96 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 10.72M |
| Gross Profit | 1.82M |
| Operating Income | -4.47M |
| Pretax Income | -4.42M |
| Net Income | -4.50M |
| EBITDA | -3.37M |
| EBIT | -4.47M |
| Earnings Per Share (EPS) | n/a |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 3.25M |
| Total Debt | 6.62M |
| Net Cash | -3.37M |
| Net Cash Per Share | -$1.39 |
| Equity (Book Value) | 32.48M |
| Book Value Per Share | 1,855.16 |
| Working Capital | 5.78M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -865,760 |
| Capital Expenditures | -4.76M |
| Depreciation & Amortization | 1.10M |
| Net Borrowing | -2.65M |
| Free Cash Flow | -5.62M |
| FCF Per Share | -$2.32 |
Margins
| Measure | Value |
|---|
| Gross Margin | 16.97% |
| Operating Margin | -41.68% |
| Pretax Margin | -41.26% |
| Profit Margin | -41.95% |
| EBITDA Margin | -31.44% |
| EBIT Margin | -41.68% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -185.72% |
| FCF Yield | -232.32% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Jun 18, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:100 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 0.66 |
| Piotroski F-Score | 2 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |